WEST PHARMACEUTICAL SERVICES INC Quarterly Income Tax Expense (Benefit) in USD from Q1 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
West Pharmaceutical Services Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2010 to Q2 2024.
  • West Pharmaceutical Services Inc Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $21.9M, a 37.1% decline year-over-year.
  • West Pharmaceutical Services Inc Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $102M, a 5.11% decline year-over-year.
  • West Pharmaceutical Services Inc annual Income Tax Expense (Benefit) for 2023 was $122M, a 6.63% increase from 2022.
  • West Pharmaceutical Services Inc annual Income Tax Expense (Benefit) for 2022 was $115M, a 7% increase from 2021.
  • West Pharmaceutical Services Inc annual Income Tax Expense (Benefit) for 2021 was $107M, a 47.9% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $102M $21.9M -$12.9M -37.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-25
Q1 2024 $115M $16.4M -$7.2M -30.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-25
Q4 2023 $122M $34.5M +$5.6M +19.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 $117M $29.4M +$9M +44.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-26
Q2 2023 $108M $34.8M -$9.4M -21.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-25
Q1 2023 $117M $23.6M +$2.4M +11.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-25
Q4 2022 $115M $28.9M -$5.3M -15.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 $120M $20.4M +$8.4M +70% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-26
Q2 2022 $112M $44.2M +$11.9M +36.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-27
Q1 2022 $99.7M $21.2M -$7.5M -26.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-27
Q4 2021 $107M $34.2M +$13.8M +67.6% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 $93.4M $12M -$9.1M -43.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-27
Q2 2021 $103M $32.3M +$16.3M +102% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-28
Q1 2021 $86.2M $28.7M +$13.7M +91.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-28
Q4 2020 $72.5M $20.4M +$3.9M +23.6% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-21
Q3 2020 $68.6M $21.1M +$10.2M +93.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-28
Q2 2020 $58.4M $16M +$500K +3.23% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 $57.9M $15M -$1.1M -6.83% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 $59M $16.5M +$1.6M +10.7% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-22
Q3 2019 $57.4M $10.9M +$2.9M +36.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-23
Q2 2019 $54.5M $15.5M +$9.5M +158% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-24
Q1 2019 $45M $16.1M +$3.6M +28.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-24
Q4 2018 $41.4M $14.9M -$46.9M -75.9% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-23
Q3 2018 $88.3M $8M -$6M -42.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-29
Q2 2018 $94.3M $6M +$3.1M +107% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-29
Q1 2018 $91.2M $12.5M +$10.3M +468% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $80.9M $61.8M +$45.7M +284% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-24
Q3 2017 $35.2M $14M -$400K -2.78% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-30
Q2 2017 $35.6M $2.9M -$14.1M -82.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-31
Q1 2017 $49.7M $2.2M -$4.7M -68.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $54.4M $16.1M +$4.9M +43.8% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $49.5M $14.4M +$21M Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-31
Q2 2016 $28.5M $17M +$7.8M +84.8% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-01
Q1 2016 $20.7M $6.9M -$5.6M -44.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q4 2015 $26.3M $11.2M -$500K -4.27% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-26
Q3 2015 $26.8M -$6.6M -$18.3M -156% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-31
Q2 2015 $45.1M $9.2M -$4.8M -34.3% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-01
Q1 2015 $49.9M $12.5M +$2.7M +27.6% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $47.2M $11.7M +$1M +9.35% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-28
Q3 2014 $46.2M $11.7M +$1.1M +10.4% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-02
Q2 2014 $45.1M $14M +$3.7M +35.9% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-03
Q1 2014 $41.4M $9.8M +$1.2M +14% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 $40.2M $10.7M +$3.3M +44.6% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-26
Q3 2013 $36.9M $10.6M +$1.6M +17.8% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-03
Q2 2013 $35.3M $10.3M +$3.8M +58.5% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-01
Q1 2013 $31.5M $8.6M -$1.2M -12.2% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 $32.7M $7.4M +$1.9M +34.5% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-25
Q3 2012 $30.8M $9M +$2.4M +36.4% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-04
Q2 2012 $28.4M $6.5M +$1.2M +22.6% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-05
Q1 2012 $27.2M $9.8M +$3.7M +60.7% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-06
Q4 2011 $23.5M $5.5M +$9.2M Oct 1, 2011 Dec 31, 2011 10-K 2014-02-27
Q3 2011 $14.3M $6.6M +$2.1M +46.7% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-05
Q2 2011 $12.2M $5.3M -$1.3M -19.7% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-06
Q1 2011 $13.5M $6.1M -$100K -1.61% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-04
Q4 2010 $13.6M -$3.7M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-27
Q3 2010 $4.5M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-07
Q2 2010 $6.6M Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-08-08
Q1 2010 $6.2M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.